LIPO - LIPELLA PHARMACEUTICALS INC.
2.36
-0.345 -14.619%
Share volume: 310,975
Last Updated: 06-18-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$2.70
-0.35
-0.13%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-14-2024 | 03-27-2025 | 05-14-2025 | 11-14-2025 | |
| Total revenue | 145.880 K | 136.431 K | 80.380 K | 173.666 K | 129.390 K | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 145.880 K | 136.431 K | 80.380 K | 173.666 K | 129.390 K | 0.000 | |
| -6.48% | -41.08% | 116.06% | -25.49% | -100.00% | |||
| Operating expenses | 1.364 M | 1.089 M | 1.540 M | 1.625 M | 1.457 M | 1.274 M | |
| Selling general and admin | 520.926 K | 427.062 K | 493.102 K | 562.622 K | 463.736 K | 553.299 K | |
| Research and development | 842.600 K | 661.558 K | 1.047 M | 1.062 M | 993.475 K | 720.973 K | |
| Total expenses | 1.364 M | 1.089 M | 1.540 M | 1.625 M | 1.457 M | 1.274 M | |
| -20.16% | 41.44% | 5.53% | -10.32% | -12.55% | |||
| Operating income | -1.218 M | -952.189 K | -1.459 M | -1.451 M | -1.328 M | -1.274 M | |
| Ebit | -1.218 M | -952.189 K | -1.459 M | -1.451 M | -1.328 M | -1.274 M | |
| Pretax income | -1.192 M | -938.146 K | -1.445 M | -1.442 M | -1.307 M | -1.254 M | |
| -21.28% | 53.99% | -0.21% | -9.37% | -4.01% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.192 M | -938.146 K | -1.445 M | -1.442 M | -1.307 M | -1.254 M | |
| 21.28% | -53.99% | 0.21% | 9.37% | 4.01% |